SCHEMBL6311488

SCHEMBL6311488

CCCCc1c(C)c(C#N)c2[nH]c3ccccc3n2c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 13/20 1.00
GAA P10253 11/20 1.00
ALDH1A1 P00352 9/20 1.00
HPGD P15428 8/20 1.00
HTT P42858 5/20 1.00
APAF1 O14727 3/20 1.00
LMNA P02545 2/20 1.00
NOD2 Q9HC29 1/20 1.00
MAPT P10636 10/20 0.76
SMN1; SMN2 Q16637 4/20 0.76
RAB9A P51151 4/20 0.76
GLA P06280 6/20 0.74
KMT2A Q03164 7/20 0.72
STAT6 P42226 1/20 0.72
HIF1A Q16665 1/20 0.72
NPSR1 Q6W5P4 3/20 0.72
ATM Q13315 1/20 0.72
TDP1 Q9NUW8 2/20 0.66
CRHBP P24387 1/20 0.57
CRHR2 Q13324 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6649614 0.95 KDM4E (0.91) KDM4EGAAALDH1A1HPGDHTT
SCHEMBL6311878 0.95 KDM4E (0.91) KDM4EGAAALDH1A1HPGDHTT
SCHEMBL6652217 0.89 KDM4E (0.81) KDM4EGAAALDH1A1HPGDHTT
SCHEMBL6311835 0.89 KDM4E (0.80) KDM4EGAAALDH1A1HPGDHTT
SCHEMBL6651151 0.87 KDM4E (0.77) KDM4EGAAALDH1A1HPGDHTT
SCHEMBL6650582 0.85 KDM4E (0.74) KDM4EGAAALDH1A1HPGDHTT
SCHEMBL6650813 0.85 KDM4E (0.74) KDM4EGAAALDH1A1HPGDHTT
SCHEMBL6313764 0.84 KDM4E (0.72) KDM4EGAAALDH1A1HPGDHTT
SCHEMBL6652182 0.84 KDM4E (0.72) KDM4EGAAALDH1A1HPGDHTT
SCHEMBL6312748 0.84 KDM4E (1.00) KDM4EGAAALDH1A1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 KDM4E 3360/4885GAA 58/4885ALDH1A1 2550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.